Welcome to DU!
The truly grassroots left-of-center political community where regular people, not algorithms, drive the discussions and set the standards.
Join the community:
Create a free account
Support DU (and get rid of ads!):
Become a Star Member
Latest Breaking News
Editorials & Other Articles
General Discussion
The DU Lounge
All Forums
Issue Forums
Culture Forums
Alliance Forums
Region Forums
Support Forums
Help & Search
Hydroxychloroquine did not prevent Covid-19 in the first controlled clinical trial.
Source: New York Times
LIVE UPDATES
-snip-
Hydroxychloroquine did not prevent Covid-19 in the first controlled clinical trial.
The malaria drug hydroxychloroquine did not prevent Covid-19 in a rigorous study of 821 people who had been exposed to patients infected with the virus, researchers from the University of Minnesota and Canada are reporting Wednesday.
The study was the first controlled clinical trial of hydroxychloroquine, a drug that President Trump has repeatedly promoted and said he had taken himself to try to ward off the virus.
Conducted in the United States and Canada, the trial was the first to test whether the drug could prevent illness in people who have been exposed to the virus. This type of study, in which patients are picked at random to receive either an experimental treatment or a placebo, is considered the most reliable way to measure the safety and effectiveness of a drug.
“The take-home message for the general public is that if you’re exposed to someone with Covid-19, hydroxychloroquine is not an effective post-exposure, preventive therapy,” the lead author of the study, Dr. David R. Boulware of the University of Minnesota, said in an interview.
The results are being published in The New England Journal of Medicine.
-snip-
-snip-
Hydroxychloroquine did not prevent Covid-19 in the first controlled clinical trial.
The malaria drug hydroxychloroquine did not prevent Covid-19 in a rigorous study of 821 people who had been exposed to patients infected with the virus, researchers from the University of Minnesota and Canada are reporting Wednesday.
The study was the first controlled clinical trial of hydroxychloroquine, a drug that President Trump has repeatedly promoted and said he had taken himself to try to ward off the virus.
Conducted in the United States and Canada, the trial was the first to test whether the drug could prevent illness in people who have been exposed to the virus. This type of study, in which patients are picked at random to receive either an experimental treatment or a placebo, is considered the most reliable way to measure the safety and effectiveness of a drug.
“The take-home message for the general public is that if you’re exposed to someone with Covid-19, hydroxychloroquine is not an effective post-exposure, preventive therapy,” the lead author of the study, Dr. David R. Boulware of the University of Minnesota, said in an interview.
The results are being published in The New England Journal of Medicine.
-snip-
Read more: https://www.nytimes.com/2020/06/03/world/coronavirus-live.html?action=click&module=Top%20Stories&pgtype=Homepage#link-11655606
1 replies
= new reply since forum marked as read
= new reply since forum marked as read
